Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: Potential role of cytokines in clinical manifestations

Leukemia and Lymphoma

Volumn 40, Issue 5-6, 2001, Pages 599-611

  Al Hashmi, I ^a   Decoteau, J ^a   Gruss, H J ^a   Zielenska, M ^a   Thorner, P ^a   Poon, A ^a   Reis, M ^a   Freedman, M ^a   Lorenzana, A ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

ALCL; CD30; Cell line; Cytokine; Large cell lymphoma; T(2; 5) translocation

Indexed keywords

CD30 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; LIGAND; MESSENGER RNA;

ACCESSORY CELL; ADVANCED CANCER; ANAPLASTIC CARCINOMA; ARTICLE; BONE MARROW DISEASE; CANCER CELL CULTURE; CASE REPORT; CELL LINEAGE; CHILD; CHILD HEALTH; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 5; CLINICAL EXAMINATION; CLINICAL FEATURE; CYTOGENETICS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IRRITABILITY; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; LYMPHOMA CELL LINE; MACROPHAGE; MONOCYTE; NEUTROPHILIA; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WEIGHT REDUCTION;

EID: 0035052460     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097658     Document Type: Article

References (38)

1. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma
2. Updated Kiel classification for lymphomas
3. Production of a monoclonal antibody specific for Hodgkin's and Sternberg-Reed cells of Hodgkin's disease and a subset of lymphoid cells
4. Ki-1-positive large cell lymphoma: A clinicopathologic study of 41 cases
5. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: A pediatric oncology group study
6. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35)
7. CD30-positive large cell lymphomas ("Ki-1 lymphoma") are associated with a chromosomal translocation involving 5q35
8. Malignant histiocytosis: A specific t(2;5)(p23;q35) translocation? Review of the literature
9. Molecular characterization of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma (ki-1) and Hodgkin's disease
10. Cytokines in malignant lymphomas: Review and prospective evaluation
11. Hodgkin's disease: A cytokine-producing tumor-review
12. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis
13. Spontaneous production of interleukin-6 by Ki-1-positive large cell anaplastic lymphoma with extensive bone destruction
14. Ki-1 lymphoma producing G-CSF
15. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor
16. Paget disease, complicated by Ki-1 lymphoma with G-CSF growth factor secretion
17. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in Non-Hodgkin's lymphoma
18. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization
19. Constitutive expression and role in growth regulation of interleukin-1 and multiple cytokine receptors in a biphenotypic leukemic cell line
20. Co-expression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis
21. Ki-1 lymphomas in childhood: Immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker
22. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction
23. Distribution of the CD68 macrophage/myeloid associated antigen
24. Malignant histiocytosis with rearrangement of the heavy chain gene and evidence of monocyte-macrophage lineage
25. Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: Guidelines for differential diagnosis-Report of the histiocyte society
26. Genotypic analysis of large cell lymphomas which express the Ki-1 antigen
27. Malignant histiocytosis. A phenotypic and genotypic investigation
28. Toward a new definition of malignant histiocytosis in children
29. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
30. Additive effects of interleukin-1 and tumor necrosis factor-a on the accumulation of the three granulocyte and macrophage colony stimulating factor mRNAs in human endothelial cells
31. Cachectin (tumor necrosis factor): A macrophage hormone governing cellular metabolism and inflammatory response
32. The biology of interleukin-6
33. Interferon-gamma: A review
34. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth
35. Tumor progression in Ki-1 cutaneous T-cell lymphomas is related to escape from inhibition by transforming growth factor-beta
36. The role of Ki-1 antigen in the autocrine TGF-beta growth regulation of Reed-Sternberg cells, Ki-1 lymphoma cells and activated thymocytes
37. Interleukin-1 and interleukin-1 antagonism
38. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta